Skip to main content
Premium Trial:

Request an Annual Quote

Adel Mahmoud

Premium
Becton Dickinson said this week that it has elected Adel Mahmoud to its board of directors.
 
Mahmoud has been named the chief executive of the Global HIV Vaccine Enterprise, effective Sept. 1. He is currently chief medical advisor, vaccines and infectious diseases for Merck. From 1999 to 2005, Mahmoud served as president of Merck Vaccines and as a member of the management committee. He holds an MD from the University of Cairo and a DPH from the University of Ain Shams, and a PhD from the University of London’s School of Hygiene and Tropical Medicine.

The Scan

Booster Push

New data shows a decline in SARS-CoV-2 vaccine efficacy over time, which the New York Times says Pfizer is using to argue its case for a booster, even as the lower efficacy remains high.

With Help from Mr. Fluffington, PurrhD

Cats could make good study animals for genetic research, the University of Missouri's Leslie Lyons tells the Atlantic.

Man Charged With Threatening to Harm Fauci, Collins

The Hill reports that Thomas Patrick Connally, Jr., was charged with making threats against federal officials.

Nature Papers Present Approach to Find Natural Products, Method to ID Cancer Driver Mutations, More

In Nature this week: combination of cryogenic electron microscopy with genome mining helps uncover natural products, driver mutations in cancer, and more.